BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210920
DTEND;VALUE=DATE:20210922
DTSTAMP:20260515T212830
CREATED:20210423T132650Z
LAST-MODIFIED:20210423T132650Z
UID:29926-1632096000-1632268799@www.pharmajournalist.com
SUMMARY:SMi’s Aseptic Processing Conference
DESCRIPTION:Sponsored by: Innerspace\, Solo Containment and STERIS\nCo-Chairs: Richard Denk\, Senior Consultant Aseptic Processing and Containment\, SKAN AG \nJames Drinkwater\, Head of Aseptic Processing and Containment Special Interest Group\, PHSS and Head of GMP Compliance\, F Ziel GmbH \nExploring Effective Strategies and New Regulations for Compliant Pharmaceutical Manufacturing \nThe aseptic processing industry has seen many changes during its progression towards the 21st century. With advances in innovative therapeutic manufacturing such as ATMPs\, pragmatic barrier system applications\, adaptability and modularity in fill finish\, robotics and automation\, small and agile product manufacturing\, just to name a few. In 2018\, the global aseptic processing market was valued over $56 trillion and is estimated to increase in net revenue upwards $124 trillion by 2027\, with a CAGR growth of 9.18%. \nThe industry is ever changing and with the advent of innovative therapeutics taking hold\, regulators and industry leaders are prompted to take proactive approaches to get treatments to patients faster. \nJoin us to explore novel and developing technologies that tackle the most pressing challenges and push innovation in the world of aseptic processing and sterile manufacturing. \nEvent Hashtag: #SMiAseptic \nKey Highlights Include: \n\nDiscuss the revisions and the impact of Annex 1 on aseptic manufacturing with AstraZeneca\nListen to a field report on the implementation of a global contamination control program with Takeda\nExplore the applications of rapid micro methods in the manufacture of sterile products with AbbVie\nDiscover a Risk Based Approach to Cleaning and Disinfection with STERIS\nDelve into case studies of competence in global aseptic manufacturing with Fresenius Kabi\nUncover the journey of Isolation Technology in a large Biotech pharmaceutical plant with Eli Lilly\n\n Who Should Attend? \n\nValidation Managers\nSenior Microbiologists\nSenior QA’s and QC’s\nQuality Control Managers\nHeads of GMP Compliance\nQuality Assurance Experts\nTechnical Operations Leads\nLeaders in Sterility Assurance\nCleanroom Managers\nRegulatory Affairs Managers\nProduction Managers\nQuality Systems Managers\nHeads of Quality Compliance\nProcess Leaders\nSenior Auditors\nBioprocess Research & Development\n\nPLUS – Post-Conference Workshop on… \nContamination Control Measures in Good Manufacturing Practice (GMP) Applied to Aseptic Processing\nWorkshop Leaders: James Drinkwater\, Head of Aseptic Processing and Containment Special Interest Group\, PHSS and Head of GMP Compliance\, F Ziel GmbH Kevin Jenkins\, Consultant\, Quality Excellence Consulting
URL:https://www.pharmajournalist.com/event/smis-aseptic-processing-conference/
LOCATION:Copthorne Tara Hotel\, London\, UK – (Virtual Attendance Option Available)
ORGANIZER;CN="SMi Group":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
END:VCALENDAR